SlideShare a Scribd company logo
1 of 26
Download to read offline
Microbial cardiovascular and systemic disease
Cardiovascular system and septicemia
 Blood is normally axenic, it contains no microbes
 Septicemia refers to microbial infection of the blood which can
lead to septic shock
 Depending on the type of organism, blood infections are referred
to as:
 *Bacteremia (bacterial septicemia)
 Viremia
 Fungemia
 Parasitemia
Petechiae – sign of bacteremia
 Bacteria can release toxins from a site of infection into the blood
causing toxemia
 Exotoxins: i.e., neurotoxins (botulism/tetanus)
 Endotoxins: lipid A of LPS, which can lead to shock
 Severe form of toxemia with septic shock
 Streptococcal toxic-shock-like syndrome (TSLS)
 Streptococcus pyogenes
 From infections of skin/wound
 Staphylococcal toxic shock syndrome (TSS)
 Staphylococcus aureus
 From reproductive tract infections
Cardiovascular system and septicemia
 Bacterial septicemia can be associated with
 Infections of the skin/wound
 Surgical wounds
 Urinary tract infections
 Infected teeth
 Improperly sterilized kidney dialysis machines, ….
 Caused by opportunistic or nosocomial bacteria such as
 Escherichia coli, Pseudomonas aeruginosa, Neisseria meningitidis,
Haemophilus influenzae
 Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus
pyogenes
Cardiovascular system and septicemia
 Diagnosis of septicemia involves analysis of signs/symptoms
 Culturing bacteria from the blood
 In occult septicemia the exact bacterial cause is hidden
 Treatment involves
 Use of antimicrobial drugs
 Elimination of the initial site of infection (source of
septicemia)
 Intravenous fluid replacement/Antibodies against LPS
 Toxemia caused by Gram negative bacteria
Cardiovascular system and septicemia
 Blood and lymph can carry pathogens throughout the body to
cause systemic disease
 Bacterial
 Tularemia
 Plague
 Lyme disease
 Viral
 EBV (Epstein-Barr Virus)
 Cytomegalovirus
 Protozoan
 Toxoplasmosis
 Malaria
 Chaga’s disease
 Helminths
 Schistosomiasis
Microbial systemic disease
Bacterial systemic diseases - Tularemia
 Tularemia is a zoonotic disease caused by Francisella tularensis (Gram-
negative coccobacillus)
 Virulence (endotoxin and lipid
capsule – resists phagocytosis)
 Prevalence in animals as
intracellular parasite: from mammals
(rabbit ), to birds, fish, ticks, flies,
mosquitoes, mites
 Multiple mode of transmission
 bite of a tick
 contact with infected animal/animal
slaughter
 contaminated meat or water
 aerosols produced in the laboratory
Mortality rate: ~ 5% of untreated
patients
Bacterial systemic diseases - Tularemia
 Highly virulent organism
that causes
 Skin lesion (ulcer) and
swollen pus-filled lymph
nodes near the site of
infection, lymphangitis
 General symptoms may
last for months/years
 malaise, fatigue, joint
stiffness, myalgia
 Diagnosis/treatment
 Serological testing
 Antimicrobials
 Vaccine for people at risk
 Possible use of Francisella as bioterrorism weapon – nationally
notifiable disease (CDC)
Plague – Yersinia pestis (Enterobacteriaceae)
 Bubonic plague - bite of infected flea or direct contact with infected
animal
 Pneumonic plague - bacilli spread from the blood to the lungs or are
inhaled (airborne transmission)
 Plague has caused several pandemics
Xenopsylla
cheopis
Plague – Yersinia pestis
Bubo: painfully inflamed
lymph node
Darkening of dead tissues
 Plague has been called the “Black Death”
 Bubonic plague is fatal in ~50% of
cases if untreated
 Pneumonic plague is fatal in ~100%
of cases if untreated
 Urban living, rodent and flea
control, antibacterial drugs have
almost eliminated plague
 The disease is considered endemic
in states like California, Arizona,
Nevada
 Potential bioterrorism weapon:
deadly, progresses rapidly, spread
among people
Lyme disease (zoonosis)
 Caused by the spirochete
Borrelia burgdorferi
Gram negative
 Bull’s eye rash at the site of
infection
 Untreated patients can develop
severe arthritis
Lyme disease is transmitted by a deer tick (Ixodes)
 Deer tick: a 2-years life cycle
Lyme disease
 Increase in cases of Lyme
disease
 Diagnosis: detecting
antibodies against
Borrelia
 Antimicrobial drugs can
cure the Lyme disease
(first phase)
 Treatment of later
phases involves anti-
inflammatory drugs
Viral systemic diseases – Epstein Barr virus (EBV)
 HHV-4
 Implicated with several diseases, depending on the “relative vigor”
of a host’s cellular immune response
EBV and infectious mononucleosis
 EBV is transmitted via saliva, enters the blood and infects B cells,
which become enlarged with lobed nuclei
 Cytotoxic T cells kill infected B cells
 Signs and symptoms: fever, sore throat, fatigue,
enlarged lymph nods and spleen
 Diagnosis: detecting antibody against EBV
 Recover of most patients in few weeks without
specific therapy
 EBV can become latent in the oropharynx: life
long infection which rarely cause disease
Cytomegalovirus (CMV) – Herpes virus
 Most people infected with CMV are asymptomatic
 CMV remains in a latent state in various cells
 Complications in
 Immunocompromised patients
 May develop pneumonia, blindness,
 CMV mononucleosis
 Fetuses (may be teratogenic)/newborns
 ~7.5% of neonates infected with CMV
 Bodily secretions carry CMV (saliva, mucous, milk, urine, feces,
semen, vaginal secretions) – it would require a large exchange of
secretions
Cytomegalovirus (CMV) – herpes virus
 CMV infections is one of the most common infections in humans
 Transmission usually occurs via
 Sexual intercourse
 Prenatal infection
 Vaginal birth
 Blood transfusion
 Organ transplants
 Diagnosis/Treatment involve
 Owl’s eye appearance of enlarged cells, detection of CMV and
antibodies against CMV
 Interferons, anti CMV immunoglobulins, fomivirsen against
replication of CMV in retinal cells. There is no vaccine against
CMV
Protozoan diseases – Toxoplasmosis
 Toxoplasma gondii
 Nucleated cells of wild and
domesticated mammals, birds
 Immunocompromised patients can develop the disease
 Fever, inflammation of several organs, spastic paralysis,
blindness, encephalitis, and death
 Transplacental infections – (first-trimester at higher risk) can cause
spontaneous abortion, mental retardation, blindness, or microcephaly
 Healthy individuals (mostly
asymptomatic)
 Infection normally resolves
without treatment
 Humans become infected
when ingesting undercooked
contaminated meat
 Serological detection and
microscopic identification in
tissue samples
 Treatment with a combination
of drugs in AIDS patients,
pregnant women, newborns
Wash fruits and vegetables, eat well
cooked meat!!!
Protozoan diseases – Toxoplasmosis
 Definitive host
Malaria is transmitted by
Anopheles mosquito
 Plasmodium species, including
P. falciparum (blackwater
fever)/P. vivax (chronic
malaria)
 Malarial paroxysms: cycles of
fever-chills correlate with
period of erythrocyte lysis
 Anemia and jaundice
(liver/eyes)
Protozoan diseases - Malaria
Ring-stage - trophozoites
within red blood cells
 Microscopic examination of blood smears allows diagnosis of
malaria
 Serological tests for specific diagnosis
 Treatment and supportive
measures
 Antimalarial drugs
 Anti-fever medication
 Blood transfusions
 Alternative methods involve
 Limiting contact with mosquitos
carrying Plasmodium
 Malaria vaccines (development
and testing in progress)
Protozoan diseases - Malaria
 Malaria is endemic throughout the tropics and subtropics, where
Anopheles breeds
 Mosquito eradication programs eliminated the disease in
Countries like US
 Over 500 million people
are infected
 1-3 million people die
annually
Chagas’ disease – American trypanosomiasis
 Caused by Trypanosoma cruzi
 Transmitted with the feces of the bloodsucking “kissing bug”
 Major reservoirs: opossum and armadillos though most mammals,
including humans, can carry the parasite
 ~ 1% of infected humans
develop early stages (general
symptoms)
 Intermediate asymptomatic
(chronic) stage for up to ~ 20
years
 Heart failure during final
symptomatic stage
 Clusters of parasites in the
heart muscle tissue
Trypomastigotes (infective) circulating
in the blood are ingested by the kissing
bug
Chagas’ disease – American trypanosomiasis
 The disease is endemic in Central and South America
 Affects 8-15 million people
 Thousands die each
year, including children
 Early stages can be treated
but not late stages
 No vaccine exists for
Chagas’s disease
 Prevention involves measures that protect against bugs: mud
replaced with concrete/brick, insecticides …..
Schistosomiasis is caused by blood flukes
 Genus
Schistosoma
 The larval stage
cercaria burrows
into the skin
 Feeding on blood,
matures, mates, and
releases eggs
 Eggs lodge in
tissues causing
damage to several
organs
 Treatment/control: drugs that kill the
worm in the body, sewage treatment,
and snail suppression
Egg of Schistosoma mansoni
 Diagnosis: identification of eggs -
shape of the egg and location of the
spines - in stool or urine samples
 WHO (World Health Organization) estimates that over 250 million
people are infected worldwide – Asia, Africa, South America
Schistosomiasis is caused by blood flukes
Scarlike tissue surrounds the egg

More Related Content

What's hot

11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventura11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventuraShabab Ali
 
Infectious Dz Lecture #1
Infectious Dz Lecture #1Infectious Dz Lecture #1
Infectious Dz Lecture #1gotsunshyne
 
07 pathogenicity and_virulence
07 pathogenicity and_virulence07 pathogenicity and_virulence
07 pathogenicity and_virulenceMUBOSScz
 
Selected human infectious diseases part 1
Selected human infectious diseases part 1Selected human infectious diseases part 1
Selected human infectious diseases part 1Jason Sulit
 
Viral & Bacterial Infections 2
Viral & Bacterial  Infections 2Viral & Bacterial  Infections 2
Viral & Bacterial Infections 2MD Specialclass
 
Role of immune system in health & diseases
Role of immune system in health & diseasesRole of immune system in health & diseases
Role of immune system in health & diseasesSmita Shukla
 
Fat2.chapter15 (pathogenicity)
Fat2.chapter15 (pathogenicity)Fat2.chapter15 (pathogenicity)
Fat2.chapter15 (pathogenicity)Tim Husain
 
Infectious disease of pathology
Infectious disease of pathologyInfectious disease of pathology
Infectious disease of pathologyNailaawal
 
Immune responses to infectious diseases
Immune responses to infectious diseases Immune responses to infectious diseases
Immune responses to infectious diseases Hadia Azhar
 

What's hot (20)

Chapter23.
Chapter23.Chapter23.
Chapter23.
 
Infectious disease p1
Infectious disease p1Infectious disease p1
Infectious disease p1
 
Infectious Part 1
Infectious Part 1Infectious Part 1
Infectious Part 1
 
11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventura11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventura
 
Microbiology lec5
Microbiology   lec5Microbiology   lec5
Microbiology lec5
 
Pathogenesis of infection
Pathogenesis of infectionPathogenesis of infection
Pathogenesis of infection
 
Mycobacterial diseases
Mycobacterial diseasesMycobacterial diseases
Mycobacterial diseases
 
Infectious Dz Lecture #1
Infectious Dz Lecture #1Infectious Dz Lecture #1
Infectious Dz Lecture #1
 
infections and immunity
infections and immunityinfections and immunity
infections and immunity
 
07 pathogenicity and_virulence
07 pathogenicity and_virulence07 pathogenicity and_virulence
07 pathogenicity and_virulence
 
Tuberclosis
TuberclosisTuberclosis
Tuberclosis
 
Selected human infectious diseases part 1
Selected human infectious diseases part 1Selected human infectious diseases part 1
Selected human infectious diseases part 1
 
Viral & Bacterial Infections 2
Viral & Bacterial  Infections 2Viral & Bacterial  Infections 2
Viral & Bacterial Infections 2
 
1 infectious diseases
1 infectious diseases1 infectious diseases
1 infectious diseases
 
Infectious Diseases
Infectious DiseasesInfectious Diseases
Infectious Diseases
 
Role of immune system in health & diseases
Role of immune system in health & diseasesRole of immune system in health & diseases
Role of immune system in health & diseases
 
Fat2.chapter15 (pathogenicity)
Fat2.chapter15 (pathogenicity)Fat2.chapter15 (pathogenicity)
Fat2.chapter15 (pathogenicity)
 
Infectious disease of pathology
Infectious disease of pathologyInfectious disease of pathology
Infectious disease of pathology
 
Immune responses to infectious diseases
Immune responses to infectious diseases Immune responses to infectious diseases
Immune responses to infectious diseases
 
Pathogenesis41
Pathogenesis41Pathogenesis41
Pathogenesis41
 

Viewers also liked

Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...
Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...
Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...Apollo Hospitals
 
Septicemia international management guideline
Septicemia international management guidelineSepticemia international management guideline
Septicemia international management guidelineNeurologyKota
 
3. S, Iepticemia, Repsis & Shock
3. S,  Iepticemia,  Repsis &  Shock3. S,  Iepticemia,  Repsis &  Shock
3. S, Iepticemia, Repsis & ShockDrHafeez Yaqoob
 

Viewers also liked (7)

Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...
Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...
Successful treatment of two cases of Elizabethkingia meningoseptica septicemi...
 
SEPTICEMIA CLUB
SEPTICEMIA CLUBSEPTICEMIA CLUB
SEPTICEMIA CLUB
 
Septicemia international management guideline
Septicemia international management guidelineSepticemia international management guideline
Septicemia international management guideline
 
3. S, Iepticemia, Repsis & Shock
3. S,  Iepticemia,  Repsis &  Shock3. S,  Iepticemia,  Repsis &  Shock
3. S, Iepticemia, Repsis & Shock
 
sepsis
sepsissepsis
sepsis
 
Septicemia
SepticemiaSepticemia
Septicemia
 
Septicemia
SepticemiaSepticemia
Septicemia
 

Similar to 12 bio265 disease of circulatory system instructor dr di bonaventura

Infectious diseases20
Infectious diseases20Infectious diseases20
Infectious diseases20MUBOSScz
 
Why do we fall ill by riya
Why do we fall ill by riyaWhy do we fall ill by riya
Why do we fall ill by riyadgupta330
 
Why do we fall ill by riya
Why do we fall ill by riyaWhy do we fall ill by riya
Why do we fall ill by riyaDlgltsbm
 
Why do we fall ill
Why do we fall ill Why do we fall ill
Why do we fall ill Abhay Kumar
 
Intro to-immunity-with-narration
Intro to-immunity-with-narrationIntro to-immunity-with-narration
Intro to-immunity-with-narrationirenepineiro
 
Dermatology.pptx
Dermatology.pptxDermatology.pptx
Dermatology.pptxDinu85
 
Overview of disease agents and other issues
Overview of disease agents and other issuesOverview of disease agents and other issues
Overview of disease agents and other issuesZakir H. Habib
 
7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventuraShabab Ali
 
Preventing Infectious Diseases
Preventing Infectious DiseasesPreventing Infectious Diseases
Preventing Infectious Diseasestbrame
 
Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13lnguyen
 
Infectious Diseases 12
Infectious Diseases  12Infectious Diseases  12
Infectious Diseases 12pgr224
 
Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...
Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...
Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...Prof Dr Bashir Ahmed Dar
 

Similar to 12 bio265 disease of circulatory system instructor dr di bonaventura (20)

Infectious diseases20
Infectious diseases20Infectious diseases20
Infectious diseases20
 
Why do we fall ill by riya
Why do we fall ill by riyaWhy do we fall ill by riya
Why do we fall ill by riya
 
Why do we fall ill by riya
Why do we fall ill by riyaWhy do we fall ill by riya
Why do we fall ill by riya
 
Immunodeficiency disorders,2010
Immunodeficiency disorders,2010Immunodeficiency disorders,2010
Immunodeficiency disorders,2010
 
Communicable disease
Communicable diseaseCommunicable disease
Communicable disease
 
Why do we fall ill
Why do we fall ill Why do we fall ill
Why do we fall ill
 
Intro to-immunity-with-narration
Intro to-immunity-with-narrationIntro to-immunity-with-narration
Intro to-immunity-with-narration
 
Infection
InfectionInfection
Infection
 
Dermatology.pptx
Dermatology.pptxDermatology.pptx
Dermatology.pptx
 
Overview of disease agents and other issues
Overview of disease agents and other issuesOverview of disease agents and other issues
Overview of disease agents and other issues
 
7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura7 bio265 infections instructor dr di bonaventura
7 bio265 infections instructor dr di bonaventura
 
Preventing Infectious Diseases
Preventing Infectious DiseasesPreventing Infectious Diseases
Preventing Infectious Diseases
 
Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13
 
Chapter 14
Chapter 14Chapter 14
Chapter 14
 
Chapter 14 epidemiology.cj
Chapter 14 epidemiology.cjChapter 14 epidemiology.cj
Chapter 14 epidemiology.cj
 
Immunity
ImmunityImmunity
Immunity
 
Infectious Diseases 12
Infectious Diseases  12Infectious Diseases  12
Infectious Diseases 12
 
What-are-pathogens.docx
What-are-pathogens.docxWhat-are-pathogens.docx
What-are-pathogens.docx
 
Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...
Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...
Meningitis By Dr Bashir Ahmed Dar Associate Professor Medicine Chinkipora Sop...
 
Introduction to infectious diseases
Introduction to infectious diseasesIntroduction to infectious diseases
Introduction to infectious diseases
 

More from Shabab Ali

Preanalytical variables in coagulation testing
Preanalytical variables in coagulation testingPreanalytical variables in coagulation testing
Preanalytical variables in coagulation testingShabab Ali
 
Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiologyShabab Ali
 
Lecture 9, fall 2014
Lecture 9, fall 2014Lecture 9, fall 2014
Lecture 9, fall 2014Shabab Ali
 
Lecture 8, fall 2014
Lecture 8, fall 2014Lecture 8, fall 2014
Lecture 8, fall 2014Shabab Ali
 
Lecture 7, fall 2014
Lecture 7, fall 2014Lecture 7, fall 2014
Lecture 7, fall 2014Shabab Ali
 
Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Shabab Ali
 
Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Shabab Ali
 
Lecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfLecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfShabab Ali
 
Lecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfLecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfShabab Ali
 
Lecture 3, spring 2014
Lecture 3, spring 2014Lecture 3, spring 2014
Lecture 3, spring 2014Shabab Ali
 
Lecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfLecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfShabab Ali
 
Lecture 1, fall 2014
Lecture 1, fall 2014Lecture 1, fall 2014
Lecture 1, fall 2014Shabab Ali
 
Colonial morphology
Colonial morphologyColonial morphology
Colonial morphologyShabab Ali
 
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6  1 xbc and 1xcs _dr di bonaventuraBio265 lab 6  1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventuraShabab Ali
 
10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventuraShabab Ali
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventuraShabab Ali
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy
5 bio265 antimicrobial agents instructor dr di bonaventura   copy5 bio265 antimicrobial agents instructor dr di bonaventura   copy
5 bio265 antimicrobial agents instructor dr di bonaventura copyShabab Ali
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)Shabab Ali
 
4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventuraShabab Ali
 
3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventuraShabab Ali
 

More from Shabab Ali (20)

Preanalytical variables in coagulation testing
Preanalytical variables in coagulation testingPreanalytical variables in coagulation testing
Preanalytical variables in coagulation testing
 
Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiology
 
Lecture 9, fall 2014
Lecture 9, fall 2014Lecture 9, fall 2014
Lecture 9, fall 2014
 
Lecture 8, fall 2014
Lecture 8, fall 2014Lecture 8, fall 2014
Lecture 8, fall 2014
 
Lecture 7, fall 2014
Lecture 7, fall 2014Lecture 7, fall 2014
Lecture 7, fall 2014
 
Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014
 
Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014
 
Lecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfLecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdf
 
Lecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfLecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdf
 
Lecture 3, spring 2014
Lecture 3, spring 2014Lecture 3, spring 2014
Lecture 3, spring 2014
 
Lecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfLecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdf
 
Lecture 1, fall 2014
Lecture 1, fall 2014Lecture 1, fall 2014
Lecture 1, fall 2014
 
Colonial morphology
Colonial morphologyColonial morphology
Colonial morphology
 
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6  1 xbc and 1xcs _dr di bonaventuraBio265 lab 6  1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
 
10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy
5 bio265 antimicrobial agents instructor dr di bonaventura   copy5 bio265 antimicrobial agents instructor dr di bonaventura   copy
5 bio265 antimicrobial agents instructor dr di bonaventura copy
 
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)5 bio265 antimicrobial agents instructor dr di bonaventura   copy (1)
5 bio265 antimicrobial agents instructor dr di bonaventura copy (1)
 
4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura4 bio265 metabolism instructor dr di bonaventura
4 bio265 metabolism instructor dr di bonaventura
 
3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura3 bio265 microbial growth instructor dr di bonaventura
3 bio265 microbial growth instructor dr di bonaventura
 

Recently uploaded

Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxUmerFayaz5
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxpradhanghanshyam7136
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfWadeK3
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physicsvishikhakeshava1
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 

Recently uploaded (20)

Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptx
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptx
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physics
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 

12 bio265 disease of circulatory system instructor dr di bonaventura

  • 1. Microbial cardiovascular and systemic disease
  • 2. Cardiovascular system and septicemia  Blood is normally axenic, it contains no microbes  Septicemia refers to microbial infection of the blood which can lead to septic shock  Depending on the type of organism, blood infections are referred to as:  *Bacteremia (bacterial septicemia)  Viremia  Fungemia  Parasitemia Petechiae – sign of bacteremia
  • 3.  Bacteria can release toxins from a site of infection into the blood causing toxemia  Exotoxins: i.e., neurotoxins (botulism/tetanus)  Endotoxins: lipid A of LPS, which can lead to shock  Severe form of toxemia with septic shock  Streptococcal toxic-shock-like syndrome (TSLS)  Streptococcus pyogenes  From infections of skin/wound  Staphylococcal toxic shock syndrome (TSS)  Staphylococcus aureus  From reproductive tract infections Cardiovascular system and septicemia
  • 4.  Bacterial septicemia can be associated with  Infections of the skin/wound  Surgical wounds  Urinary tract infections  Infected teeth  Improperly sterilized kidney dialysis machines, ….  Caused by opportunistic or nosocomial bacteria such as  Escherichia coli, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae  Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes Cardiovascular system and septicemia
  • 5.  Diagnosis of septicemia involves analysis of signs/symptoms  Culturing bacteria from the blood  In occult septicemia the exact bacterial cause is hidden  Treatment involves  Use of antimicrobial drugs  Elimination of the initial site of infection (source of septicemia)  Intravenous fluid replacement/Antibodies against LPS  Toxemia caused by Gram negative bacteria Cardiovascular system and septicemia
  • 6.  Blood and lymph can carry pathogens throughout the body to cause systemic disease  Bacterial  Tularemia  Plague  Lyme disease  Viral  EBV (Epstein-Barr Virus)  Cytomegalovirus  Protozoan  Toxoplasmosis  Malaria  Chaga’s disease  Helminths  Schistosomiasis Microbial systemic disease
  • 7. Bacterial systemic diseases - Tularemia  Tularemia is a zoonotic disease caused by Francisella tularensis (Gram- negative coccobacillus)  Virulence (endotoxin and lipid capsule – resists phagocytosis)  Prevalence in animals as intracellular parasite: from mammals (rabbit ), to birds, fish, ticks, flies, mosquitoes, mites  Multiple mode of transmission  bite of a tick  contact with infected animal/animal slaughter  contaminated meat or water  aerosols produced in the laboratory Mortality rate: ~ 5% of untreated patients
  • 8. Bacterial systemic diseases - Tularemia  Highly virulent organism that causes  Skin lesion (ulcer) and swollen pus-filled lymph nodes near the site of infection, lymphangitis  General symptoms may last for months/years  malaise, fatigue, joint stiffness, myalgia  Diagnosis/treatment  Serological testing  Antimicrobials  Vaccine for people at risk  Possible use of Francisella as bioterrorism weapon – nationally notifiable disease (CDC)
  • 9. Plague – Yersinia pestis (Enterobacteriaceae)  Bubonic plague - bite of infected flea or direct contact with infected animal  Pneumonic plague - bacilli spread from the blood to the lungs or are inhaled (airborne transmission)  Plague has caused several pandemics Xenopsylla cheopis
  • 10. Plague – Yersinia pestis Bubo: painfully inflamed lymph node Darkening of dead tissues  Plague has been called the “Black Death”  Bubonic plague is fatal in ~50% of cases if untreated  Pneumonic plague is fatal in ~100% of cases if untreated  Urban living, rodent and flea control, antibacterial drugs have almost eliminated plague  The disease is considered endemic in states like California, Arizona, Nevada  Potential bioterrorism weapon: deadly, progresses rapidly, spread among people
  • 11. Lyme disease (zoonosis)  Caused by the spirochete Borrelia burgdorferi Gram negative  Bull’s eye rash at the site of infection  Untreated patients can develop severe arthritis
  • 12. Lyme disease is transmitted by a deer tick (Ixodes)  Deer tick: a 2-years life cycle
  • 13. Lyme disease  Increase in cases of Lyme disease  Diagnosis: detecting antibodies against Borrelia  Antimicrobial drugs can cure the Lyme disease (first phase)  Treatment of later phases involves anti- inflammatory drugs
  • 14. Viral systemic diseases – Epstein Barr virus (EBV)  HHV-4  Implicated with several diseases, depending on the “relative vigor” of a host’s cellular immune response
  • 15. EBV and infectious mononucleosis  EBV is transmitted via saliva, enters the blood and infects B cells, which become enlarged with lobed nuclei  Cytotoxic T cells kill infected B cells  Signs and symptoms: fever, sore throat, fatigue, enlarged lymph nods and spleen  Diagnosis: detecting antibody against EBV  Recover of most patients in few weeks without specific therapy  EBV can become latent in the oropharynx: life long infection which rarely cause disease
  • 16. Cytomegalovirus (CMV) – Herpes virus  Most people infected with CMV are asymptomatic  CMV remains in a latent state in various cells  Complications in  Immunocompromised patients  May develop pneumonia, blindness,  CMV mononucleosis  Fetuses (may be teratogenic)/newborns  ~7.5% of neonates infected with CMV  Bodily secretions carry CMV (saliva, mucous, milk, urine, feces, semen, vaginal secretions) – it would require a large exchange of secretions
  • 17. Cytomegalovirus (CMV) – herpes virus  CMV infections is one of the most common infections in humans  Transmission usually occurs via  Sexual intercourse  Prenatal infection  Vaginal birth  Blood transfusion  Organ transplants  Diagnosis/Treatment involve  Owl’s eye appearance of enlarged cells, detection of CMV and antibodies against CMV  Interferons, anti CMV immunoglobulins, fomivirsen against replication of CMV in retinal cells. There is no vaccine against CMV
  • 18. Protozoan diseases – Toxoplasmosis  Toxoplasma gondii  Nucleated cells of wild and domesticated mammals, birds  Immunocompromised patients can develop the disease  Fever, inflammation of several organs, spastic paralysis, blindness, encephalitis, and death  Transplacental infections – (first-trimester at higher risk) can cause spontaneous abortion, mental retardation, blindness, or microcephaly  Healthy individuals (mostly asymptomatic)  Infection normally resolves without treatment
  • 19.  Humans become infected when ingesting undercooked contaminated meat  Serological detection and microscopic identification in tissue samples  Treatment with a combination of drugs in AIDS patients, pregnant women, newborns Wash fruits and vegetables, eat well cooked meat!!! Protozoan diseases – Toxoplasmosis  Definitive host
  • 20. Malaria is transmitted by Anopheles mosquito  Plasmodium species, including P. falciparum (blackwater fever)/P. vivax (chronic malaria)  Malarial paroxysms: cycles of fever-chills correlate with period of erythrocyte lysis  Anemia and jaundice (liver/eyes)
  • 21. Protozoan diseases - Malaria Ring-stage - trophozoites within red blood cells  Microscopic examination of blood smears allows diagnosis of malaria  Serological tests for specific diagnosis  Treatment and supportive measures  Antimalarial drugs  Anti-fever medication  Blood transfusions  Alternative methods involve  Limiting contact with mosquitos carrying Plasmodium  Malaria vaccines (development and testing in progress)
  • 22. Protozoan diseases - Malaria  Malaria is endemic throughout the tropics and subtropics, where Anopheles breeds  Mosquito eradication programs eliminated the disease in Countries like US  Over 500 million people are infected  1-3 million people die annually
  • 23. Chagas’ disease – American trypanosomiasis  Caused by Trypanosoma cruzi  Transmitted with the feces of the bloodsucking “kissing bug”  Major reservoirs: opossum and armadillos though most mammals, including humans, can carry the parasite  ~ 1% of infected humans develop early stages (general symptoms)  Intermediate asymptomatic (chronic) stage for up to ~ 20 years  Heart failure during final symptomatic stage  Clusters of parasites in the heart muscle tissue Trypomastigotes (infective) circulating in the blood are ingested by the kissing bug
  • 24. Chagas’ disease – American trypanosomiasis  The disease is endemic in Central and South America  Affects 8-15 million people  Thousands die each year, including children  Early stages can be treated but not late stages  No vaccine exists for Chagas’s disease  Prevention involves measures that protect against bugs: mud replaced with concrete/brick, insecticides …..
  • 25. Schistosomiasis is caused by blood flukes  Genus Schistosoma  The larval stage cercaria burrows into the skin  Feeding on blood, matures, mates, and releases eggs  Eggs lodge in tissues causing damage to several organs
  • 26.  Treatment/control: drugs that kill the worm in the body, sewage treatment, and snail suppression Egg of Schistosoma mansoni  Diagnosis: identification of eggs - shape of the egg and location of the spines - in stool or urine samples  WHO (World Health Organization) estimates that over 250 million people are infected worldwide – Asia, Africa, South America Schistosomiasis is caused by blood flukes Scarlike tissue surrounds the egg